PODCAST

Uncensored: The Real Talk on Rare & Pharma in BeNeLux

The Karel FOL Management podcast brings you honest conversations with founders, scientists and business experts. Discover how early-stage ideas grow into impactful companies, and gain insights to support your own journey as a start-up.

This podcast brings bold, candid conversations from the frontlines of BioPharma, Rare Diseases, and healthcare strategy across Belgium and the broader BeNeLux region.

As your host, I’ll draw from decades in the industry to dive deep with thought leaders, disruptors, and changemakers—unpacking what it really takes to launch innovative therapies, secure market access, navigate regulations, and drive commercial success in one of Europe’s most complex and exciting life sciences ecosystems.

Listen to my third podcast
The host, Karel FOL, invites Mitchell Silva, an expert in creating insights & solutions to turn patient engagement strategies into reality via his companies Esperity & Patient Centrics.
 

We build a PARENT SUPPORT PROGRAM to customize information on disease and treatment to the patient’s profile. This platform was developed in collaboration with a University Hospital Department for & with the parents of SMA-patients.

Listen to my second podcast

“BeNeLuxA-I: a Multi-country Reimbursement Procedure for Innovative Medicinal Products” with Katrien De Groote.

The host, Karel FOL, invites Katrien de Groote, an expert in market access/reimbursement for innovative medicinal products, to guide us through the BeNeLuxA-I-procedure.

The Beneluxa-i Initiative on Pharmaceutical Policy is an initiative involving health services in Belgium, The Netherlands, Austria, Ireland and  to deliver sustainable access to innovative medications to people in these smaller countries.

Listen to my first podcast

“Why is the Rare Disease business different compared to the traditional Big Pharma business dynamic?” with Tom Meuleman

I invited Tom Meuleman, a Rare Disease veteran, to guide us through the differences between Rare Diseases and traditional Big Pharma business dynamics.

I’d love to hear your thoughts, feedback, and suggestions for future topics or guests.

Let’s talk rare, real, and uncensored. 

 

Where the podcast journey began

At the end of 2023 I was asked by Olivia Janssens from United Talent to join her for a Podcast on how I look at my career, my experiences and why I believe I generated some successes. It was shared on LinkedIn in January 2024. And I really liked the process and outcome.

So once I decided I would set up my own Mgm Company I reflected on doing the same kind of Podcasts with people i worked with on specific projects. I really liked working with them, and as I am proud of the outcome of these shared projects, I am happy to share our experiences.

First podcast to be released very soon…. Stay tuned!

Any questions or interest?